top of page
Publications
Antibodies to treat T cell leukemias and lymphomas
Our latest publication detailing the development of bispecific antibodies that selectively kill T cell leukemias and lymphomas and do not harm the normal human T cells
Science Translational Medicine 2021
Antibody targeting cancers with p53 mutation
Mutations in p53 tumor suppression gene leads to cancer. We generated an antibody that specifically kills the cancer cells carrying the mutant p53 protein.
Antibodies targeting cancers with RAS mutations
Mutations in RAS oncogene lead to cancer. We generated an antibody that specifically kills the cancer cells carrying the mutant p53 protein.
Science Immunology 2021
In the news



Links
Sidney Kimmel Comprehensive Cancer Center
Lymphoma Division
CAR T cell Program
Bone Marrow Transplant Program
Suman Paul Faculty Profile
Location
1650 Orleans Street, CRB1, Room 3M90, Baltimore, MD 21287
Contacts
419-614-3900
Research Support






bottom of page